CDBioSciences - VLPlant

CD BioSciences is a leading customer-focused biotechnology company founded in New York. Virus-like particles (VLPs) constructed on plant-based platforms can be produced on a large scale as plants can be grown cheaply and efficiently without the need for expensive cell culture facilities associated with fermentation systems. Additionally, the risk of plant introduction of foreign human pathogens is very low. CD BioSciences is committed to providing customers with a wide range of high-quality and reliable VLP plant construction platform services and applications to advance the development of VLP-based vaccines, nanomaterials and diagnostics. As a pioneer in biotechnology, CD BioSciences has grown to become one of the largest independent biotechnology companies in the world and is connected to millions of researchers and partners worldwide.